Coronaviruses are a family of enveloped RNA viruses that infect a wide variety of birds and mammals, including humans. They are best known in the public eye for causing severe outbreaks such as SARS, MERS and COVID‑19, but the family also includes viruses that cause mild respiratory illness in people and disease in animals. The viral particles have a distinctive appearance under electron microscopy that inspired the name "coronavirus" (from the Latin corona, meaning crown), a reference to the crownlike spikes on the virion surface. Researchers study coronaviruses to understand their biology, their capacity to jump between species, and to design measures for prevention and treatment. Overview and classification

Structure and defining components

Coronaviruses are enveloped and carry a single-stranded, positive-sense RNA genome. The virion surface is studded with large glycoprotein spikes (S, or spike protein) that mediate attachment and entry into host cells and largely determine which species and cell types the virus can infect. Other conserved structural proteins include the membrane protein (M), the envelope protein (E) and the nucleocapsid protein (N), which packages the viral genome. These proteins and the envelope account for the virus's morphology and are common targets for laboratory diagnostics and vaccine design. Key structural proteins

Genetic features and replication

The coronavirus genome is unusually large for an RNA virus, typically about 26–32 kilobases. It is organized into open reading frames that produce both structural proteins and a set of nonstructural proteins required for replication. Coronaviruses replicate in the cytoplasm of infected cells, using a multi-protein replication complex that synthesizes new RNA genomes and subgenomic RNAs for protein production. Many coronaviruses encode a proofreading activity that helps maintain genome integrity despite the high mutation rates usually associated with RNA viruses. The genome size and replication strategy contribute to the family’s capacity for genetic change through mutation and recombination. Genome and replication

Groups, hosts and disease spectrum

The family is conventionally divided into four genera commonly called alpha, beta, gamma and delta coronaviruses. Alpha‑ and beta‑coronaviruses mainly infect mammals, while gamma‑ and delta‑types are more often found in birds, though there are exceptions. In humans, some coronaviruses cause mild upper respiratory infections—colloquially referred to as some causes of the common cold—while others have produced severe lower respiratory disease with high morbidity and mortality. Examples of notable human illnesses include:

  • SARS (Severe Acute Respiratory Syndrome), recognized in 2002–2003.
  • MERS (Middle East Respiratory Syndrome), identified in 2012.
  • COVID‑19, caused by SARS‑CoV‑2 and first reported in 2019.

Coronaviruses transmit by respiratory droplets, close contact and, in some settings, contact with contaminated surfaces; many also circulate in animal reservoirs and can spill over to humans, a process often linked to close human–animal interactions. Host range and transmission

History, research and public health

Viruses now classified as coronaviruses were first identified in the mid‑20th century using electron microscopy, which revealed their halo‑like surface projections. Since then, research has expanded into molecular virology, ecology, diagnostics, therapeutics and vaccine development. The global impact of recent coronavirus outbreaks has emphasized the need for surveillance at the human–animal interface, rapid diagnostic capacity, and investment in vaccines and antiviral drugs. Control measures during outbreaks commonly include infection prevention practices, testing and isolation, targeted vaccination where available, and public health interventions tailored to transmission routes. Historical milestones Public health response

Notable scientific and clinical considerations

Because coronaviruses can mutate and recombine, ongoing genomic surveillance is important to detect emerging variants that might affect transmissibility, disease severity or the effectiveness of countermeasures. Vaccines and therapeutics for human coronaviruses vary by pathogen: some illnesses have approved vaccines or licensed treatments, while others remain the focus of active research. In animals, coronaviruses can affect agricultural production and wildlife health, which has economic and ecological implications. Surveillance Vaccines and therapeutics Animal health Further reading